Generic Sterile Injectable market

Generic Sterile Injectable Market - Global Outlook and Forecast 2022-2028

  • 15 March 2022
  • Life Sciences
  • 77 Pages
  • Report code : PMR-6940159

  • 4.7 (158)

Generic Sterile Injectable Market

COMPANIES COVERED

3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy?s
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab

Download FREE Report Sample

  Download Free sample

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare industry. The generic sterile injectable are very inexpensive as compared to that of their branded counterparts of these drugs and performs equally well. Thus, these Injectables are heavily in demand all the time and are used in majority of hospitals and clinics across the globe. However, due to the stringent FDA regulations for the production of these injectable, the rigorous demand satisfaction of these injectable has always been a constant challenge for the key players in the global generic sterile injectable market.

The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable.

Generic Sterile Injectable Market contains market size and forecasts of Generic Sterile Injectable in global, including the following market information:

Global Generic Sterile Injectable Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Generic Sterile Injectable Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Generic Sterile Injectable companies in 2021 (%)

The global Generic Sterile Injectable market was valued at 52890 million in 2021 and is projected to reach US$ 77190 million by 2028, at a CAGR of 5.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Generic Sterile Injectable include 3M, Baxter Inc, Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma, Sun Pharma and Dr. Reddy?s, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Generic Sterile Injectable manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Generic Sterile Injectable Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Generic Sterile Injectable Market Segment Percentages, by Type, 2021 (%)

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccines
  • Others

Global Generic Sterile Injectable Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Generic Sterile Injectable Market Segment Percentages, by Application, 2021 (%)

  • Hospitals
  • Pharmacies
  • Online Pharmacies

Global Generic Sterile Injectable Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Generic Sterile Injectable Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Generic Sterile Injectable revenues in global market, 2017-2022 (Estimated), ($ millions)
  • Key companies Generic Sterile Injectable revenues share in global market, 2021 (%)
  • Key companies Generic Sterile Injectable sales in global market, 2017-2022 (Estimated), (K Units)
  • Key companies Generic Sterile Injectable sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • 3M
  • Baxter Inc
  • Fresenius Kabi
  • Pfizer/Hospira
  • Novartis/Sandoz
  • Teva
  • Hikma
  • Sun Pharma
  • Dr. Reddy?s
  • Mylan
  • AstraZeneca Plc
  • Merck & Co., Inc
  • Hellberg Safety Ab

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Generic Sterile Injectable Market

Leave This Empty: